Unveiling a Doxorubicin‐Cytochrome P450 Electron Transfer Pathway for Synergistic Multimodal Tumor Therapy
Small Methods · 2025
DOI: 10.1002/smtd.202501358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Wenbo Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China. Hauptthemen laut MEDLINE: Doxorubicin, Cytochrome P-450 Enzyme System, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin (DOX) is a clinically approved chemotherapeutic agent that exerts its cytotoxicity through DNA intercalation and topoisomerase II inhibition. However, its redox‐based mechanism remains underexplored. Here, it is revealed that DOX specifically binds to the heme center of cytochrome P450 (CYP450) enzymes via its quinone moiety, enabling electron transfer that catalyzes molecular oxygen into superoxide anions (O 2 •− ). To enhance this process, mesoporous polydopamine (mPDA) is introduced as an electron‐rich scaffold, amplifying electron flow to DOX. Furthermore, L‐arginine (L‐Arg) is co‐delivered to supply nitric oxide (NO), which reacts with O 2 •− to generate peroxynitrite (ONOO − ), a stable, highly cytotoxic ROS. ONOO − further activates matrix metalloproteinase (MMP), promoting extracellular matrix degradation and facilitating drug/oxygen penetration. Moreover, the system enables multimodal tumor therapy by integrating DOX‐based chemotherapy, nitric oxide (NO) gas therapy, and mPDA‐mediated photothermal therapy. This work unveils a novel DOX‐CYP450 electron transfer mechanism and establishes a synergistic therapeutic paradigm to overcome tumor microenvironmental barriers and enhance treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Lab of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- School of Science and Engineering, Shenzhen Key Laboratory of Functional Aggregate Materials, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
- Tianjin Key Laboratory of Molecular Recognition and Biosensing, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin, 300071, China.
ORCID-Profile: Yue Wang
Förderung
- National Science Fund for Distinguished Young Scholars
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipality
- National Key Research and Development Program of China
Zitieren
APA
Yin, W., Liu, Z., An, S., Song, T., Wang, Y., & Jiang, X. (2025). Unveiling a Doxorubicin‐Cytochrome P450 Electron Transfer Pathway for Synergistic Multimodal Tumor Therapy. Small Methods. https://doi.org/10.1002/smtd.202501358
Vancouver
Yin W, Liu Z, An S, Song T, Wang Y, Jiang X. Unveiling a Doxorubicin‐Cytochrome P450 Electron Transfer Pathway for Synergistic Multimodal Tumor Therapy. Small Methods. 2025. doi:10.1002/smtd.202501358
BibTeX
@article{Yin2025,
author = {Yin, Wenbo and Liu, Zonghang and An, Shangjie and Song, Tao and Wang, Yue and Jiang, Xiue},
title = {Unveiling a Doxorubicin‐Cytochrome P450 Electron Transfer Pathway for Synergistic Multimodal Tumor Therapy},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202501358}
}
EUVIMED